Filter posts

Are You Ready To Go Beyond The Cutting Edge At BIO 2016?

In an April 18 blog posted on Life Science Leader, Rob Wright outlined the essential components of a compelling and …

The Guardian: Global defence system to fight virus threats urgently needed

Fresh on the heels of the recent Ebola epidemic, the current Zika virus threat has …

Improving Oncology Clinical Trials

The 18th Annual BIO CEO & Investor Conference kicked off with a panel focused on oncology …

2015 FDA Approvals: Highest Levels in Over a Decade

2015 was a blockbuster year for FDA approvals of novel new medicines, many of them …

Know Your IP Strategy: A Necessity for Technology Start-ups

The Licensing Executives Society Foundation invites start-up companies, with investments of less than $200,000, and …

Interstitial Cystitis: Understanding What It Is, and the Interstitial Cystitis Association’s Role...

If you mention Interstitial Cystitis (IC) to most people, including physicians, the majority of people …

The Liquid Gold Rush For Biopsies

Liquid biopsy is considered “liquid gold”. Estimates the global testing market to reach $20 billion …

Setting the Record Straight on Innovation and Drug Development

Modern biotechnology is a relatively young industry, but in just over 40 years, the entrepreneurs, …

Do Outcomes Matter When There Is Chronic Misalignment?

This piece by Allan L. Shaw was originally published in Life Science Leader. With over …

See What’s New at the 2015 BIO Investor Forum

The 2015 BIO Investor Forum is just two weeks away, and it’s gearing up to …